Patent · US Active

Compounds

US7956083B2 · kind B2 · utility

0Cited by
0References
3Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 17, 2009
Grant dateJun 7, 2011
Priority date
Expiry dateFeb 17, 2029

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P37/06
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to novel indole derivatives having pharmacological activity, processes for their preparation, compositions containing them and the use of these compounds in the treatment of estrogen receptor beta mediated diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.